Tsumura Co. Strategy, SWOT and Corporate Finance Report [Report Updated: 28072018] Prices from USD $175

01:22 EDT 5 Oct 2018 | BioPortfolio Reports

Tsumura Co. Strategy, SWOT and Corporate Finance Report


Summary


Tsumura Co. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Tsumura Co. Tsumura or 'the company' is engaged in the manufacturing and sale of pharmaceutical products, including primarily prescription Kampo products. The company operates in Japan, China, South Korea and other countries. It is headquartered in Tokyo, Japan and employed 3,242 people as of March 31, 2016.


Scope


Detailed information on Tsumura Co. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Tsumura Co. in the form of a SWOT analysis

An indepth view of the business model of Tsumura Co. including a breakdown and examination of key business segments

Intelligence on Tsumura Co.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Tsumura Co., such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Tsumura Co. and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Tsumura Co. as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Tsumura Co.'s business structure, strategy and prospects.

More From BioPortfolio on "Tsumura Co. Strategy, SWOT and Corporate Finance Report [Report Updated: 28072018] Prices from USD $175"